Abstract
The health risks and side effects of fluoroquinolone use include the risk of tendon rupture and myasthenia gravis exacerbation, and on August 15, 2013, the Food and Drug Administration updated its warning to include the risk of permanent peripheral neuropathy. We present a case of fluoroquinolone-induced peripheral neuropathy in a patient treated for clinically diagnosed urinary tract infection with ciprofloxacin antibiotic.
Cite
CITATION STYLE
APA
Francis, J. K., & Higgins, E. (2014). Permanent Peripheral Neuropathy. Journal of Investigative Medicine High Impact Case Reports, 2(3). https://doi.org/10.1177/2324709614545225
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free